In pancreatic cancer, the most frequently active tumor suppressor gene is P16/CDKN2A, which blocks CDK4/6 mediated phosphorylation of retinoblastoma, which blocks entry into the S phase of the cell cycle. Here, CDKN2A is linked to familial pancreatic carcinoma.